Sort
30,917 grants matching “tumor microenvironment”
Peroxisome Proliferator-Activated Receptor (gamma) in Lung Cancer
$297,398Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2011 · CA
Peroxisome Proliferator-Activated Receptor (gamma) in Lung Cancer
$297,398Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2015 · CA
Heparanase Mechanisms in Brain-metastatic Breast Cancer
$297,350Dario Marchetti · Baylor College Of Medicine · R01 · FY2012 · CA
Heparanase Mechanisms in Brain-metastatic Breast Cancer
$297,350Dario Marchetti · Baylor College Of Medicine · R01 · FY2011 · CA
SUBNUCLEAR TARGETING AND TRANSCRPTIONAL CONTROL DURING INTERPHASE AND MITOSIS IN
$297,329Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2010 · CA
Ovarian Cancer: Mechanisms of Neuroendocrine Regulation
$297,324Anil K Sood · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas
$297,310Andreas Friedl · University Of Wisconsin-Madison · R01 · FY2010 · CA
An engineered platform for the study of metastasis (PQ #24)
$297,178Peter C Searson · Johns Hopkins University · R01 · FY2013 · CA
Host's Genes that Control Lymphocyte Infiltration of Tumors
$297,124Peter Demant · Roswell Park Cancer Institute Corp · R01 · FY2009 · CA
Regulatory T-Cells in the Tumor Microenvironment of B-Cell Non-Hodgkin
$297,057Stephen M Ansell · University Of Iowa · P50 · FY2007 · CA
Targeting MFG-E8 as Melanoma Immunotherapy
$297,042Glenn Dranoff · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Heparanase regulation of tumor host interactions in myeloma and breast cancer
$297,000Ralph D Sanderson · University Of Alabama At Birmingham · R01 · FY2008 · CA
The Role of Monocytes in non-Hodgkin Lymphoma
$296,953Stephen M Ansell · University Of Iowa · P50 · FY2012 · CA
High Throughput Screening for SCAP Inhibitors as Pancreas Cancer Therapeutics
$296,913Peter John Espenshade · Johns Hopkins University · R01 · FY2023 · CA
Regulation of the Tumor Microenvironment by KSHV
$296,881Christopher H Parsons · Medical University Of South Carolina · R01 · FY2011 · CA
The role of complement in ovarian cancer
$296,817John D Lambris · University Of Pennsylvania · R01 · FY2008 · CA
The role of complement in ovarian cancer
$296,817John D Lambris · University Of Pennsylvania · R01 · FY2007 · CA
The role of complement in ovarian cancer
$296,817John D Lambris · University Of Pennsylvania · R01 · FY2009 · CA
P38 MAP KINASE SIGNALING IN SKIN
$296,760Tatiana Efimova · Washington University · R01 · FY2014 · CA
Project 1: Optimizing a VSV-based virotherapy-based regimen for advanced MM
$296,745Martha Q Lacy · Mayo Clinic Arizona · P50 · FY2021 · CA
Determining Molecular Mechanisms of NSCLC and Response to beta-glucan
$296,727Andrew N Lane · University Of Louisville · P01 · FY2013 · CA
CD4+ Memory T-Cells in Human Tumor Microenvironment
$296,719Richard B Bankert · State University Of New York At Buffalo · R01 · FY2012 · CA
CD4+ Memory T-Cells in Human Tumor Microenvironment
$296,719Richard B Bankert · State University Of New York At Buffalo · R01 · FY2011 · CA
Engineering enzymatic activity of a cancer therapeutic tospecifically target extracellular matrix in the tumor microenvironment
$296,648Glenn E Croston · Phenzyme, Inc. · R43 · FY2017 · CA
Role of a Novel Secreted Protein Tyrosine Kinase in Development
$296,625Malcolm R. Whitman · Harvard Medical School · R21 · FY2014 · DE